IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.255
-0.005 (-0.40%)
Jun 5, 2025, 10:04 AM - Market open

IGM Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-198.87-195.8-246.42-221.1-165.16-81.36
Upgrade
Depreciation & Amortization
9.219.118.286.084.481.03
Upgrade
Loss (Gain) From Sale of Investments
-4.71-6.88-9.14-2.710.62-0.6
Upgrade
Stock-Based Compensation
35.8338.2746.5544.7125.878.45
Upgrade
Other Operating Activities
7.179.4115.1912.012.752.55
Upgrade
Change in Accounts Payable
-2.61-0.31-0.99-30.652.2
Upgrade
Change in Unearned Revenue
-2.68-2.68-2.13148.93--
Upgrade
Change in Income Taxes
-----0.04
Upgrade
Change in Other Net Operating Assets
-8.33-4.12-3.579.245.8-0.19
Upgrade
Operating Cash Flow
-143.1-153-192.23-5.85-124.98-67.88
Upgrade
Capital Expenditures
-3.4-5.85-12.38-10.21-13.24-17.5
Upgrade
Sale of Property, Plant & Equipment
0.040.04----
Upgrade
Investment in Securities
101.669.9780.74-215.4428.7175.79
Upgrade
Investing Cash Flow
98.2464.1668.36-225.6415.4658.29
Upgrade
Issuance of Common Stock
2.272.46115.07219.384.03216.51
Upgrade
Repurchase of Common Stock
-0-0---1.56-1.73
Upgrade
Other Financing Activities
-0.03-0.07----
Upgrade
Financing Cash Flow
2.242.39115.07219.382.48214.78
Upgrade
Net Cash Flow
-42.61-86.45-8.81-12.12-107.05205.19
Upgrade
Free Cash Flow
-146.5-158.85-204.61-16.06-138.23-85.38
Upgrade
Free Cash Flow Margin
-5464.27%-5929.38%-9606.20%-1502.24%--
Upgrade
Free Cash Flow Per Share
-2.41-2.63-3.91-0.39-4.13-2.78
Upgrade
Cash Income Tax Paid
--0.63---
Upgrade
Levered Free Cash Flow
-75.65-85.9-121.96-87.54-80.53-52.43
Upgrade
Unlevered Free Cash Flow
-75.65-85.9-121.96-87.54-80.53-52.43
Upgrade
Change in Net Working Capital
10.076.040.88-14.36-5.69-7.64
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q